The Phase 2 Trial Data In the key Phase 2 randomized controlled trial published in the New England Journal of Medicine in 2023 (N=338), participants receiving retatrutide 12 mg weekly lost a mean of 24.2% of body weight at 48 weeks versus 2.1% on placebo [1]
Indications and Usage for B!2 Inject Kit Cyanocobalamin is indicated for vitamin B 12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
Research is underway to determine the biological role of hormones, genetics, inflammation, and metabolism in the conditions development
Inflammatory Bowel Disease (IBD) & Leaky Gut Syndrome: They promote tissue repair and reduce inflammation
